Published online May 18, 2026. doi: 10.5312/wjo.v17.i5.116723
Revised: December 22, 2025
Accepted: February 6, 2026
Published online: May 18, 2026
Processing time: 181 Days and 1.5 Hours
Chronic pain and musculoskeletal disorders (MSDs) are prevalent and impact health around the world. Traditional treatments may not always be effective and safe.
To determine the effectiveness of vitamin C supplementation on reducing pain, improving function and supporting tissue repair in MSDs.
Randomized controlled trials, cohort studies, and observational studies that assessed the impact of vitamin C on MSDs. The Cochrane Risk of Bias tool was used to evaluate the quality of studies. Standardized mean differences (SMD) were pooled using random-effects meta-analysis.
Thirty studies were included in the meta-analysis. Vitamin C significantly reduced pain (SMD = -0.68; 95% confidence interval: -0.87 to -0.49) and improved function (SMD = 0.61; 95% confidence interval: 0.45-0.77). Collagen synthesis and inflammatory markers (C-reactive protein, interleukin-6 and tumor necrotizing factor-α) were all consistently improved.
Vitamin C supplementation might have additional benefits in some MSDs, such as reducing pain and inflammatory modulation. But there is currently little consistency in the evidence and medium quality of the methods used. No definitive therapeutic efficacy can be determined, and further well-designed, disorder-specific randomized controlled trials are required.
Core Tip: Vitamin C is a promising additive medication for musculoskeletal disorders with its potential benefits in terms of pain reduction, functional improvement, and tissue regeneration. Its effects on collagen production and reducing inflammation has been confirmed in 30 studies. Based on these results, vitamin C can be added to the treatment protocol of musculoskeletal disorders and the findings stress the need for further well-designed and tightly controlled trials to define the optimal doses and clarify the therapeutic role of vitamin C in orthopaedic medicine.